STOCK TITAN

Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) grants 38,779 shares of restricted common stock to eight newly-hired non-executive employees under the Employment Inducement Award Plan.
Positive
  • None.
Negative
  • None.

ALHAMBRA, Calif., Dec. 18, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that effective on December 15, 2023, the Compensation Committee of ApolloMed's Board of Directors (the "Committee") granted a total of 38,779 shares of restricted common stock to eight newly-hired non-executive employees, under the Apollo Medical Holdings, Inc. Employment Inducement Award Plan (the "Inducement Plan"). The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of the Company (or following a bona fide period of non-employment) as an inducement material to such individuals' commencement of employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4).

Of the restricted stock granted, 22,182 shares will vest, subject to continued employment, over four years in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date, and 16,597 shares will vest, subject to continued employment, based on the achievement of the applicable performance targets and the same time-based vesting conditions as the other shares of restricted stock granted. The restricted stock is subject to the terms and conditions of the Inducement Plan and an award agreement covering each grant.

About Apollo Medical Holdings, Inc.

ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver outcomes-based medical care to patients in a cost-effective manner.

Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and entities participating in the Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation models. For more information, please visit www.apollomed.net.

FOR MORE INFORMATION, PLEASE CONTACT:

Investor Relations
(626) 943-6491
investors@apollomed.net

Asher Dewhurst, ICR Westwicke
ApolloMedIR@westwicke.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-announces-grant-of-inducement-awards-pursuant-to-nasdaq-listing-rule-5635c4-302018194.html

SOURCE Apollo Medical Holdings, Inc.

FAQ

What is the announcement made by Apollo Medical Holdings, Inc. (AMEH) on December 18, 2023?

Apollo Medical Holdings, Inc. announced the grant of 38,779 shares of restricted common stock to eight newly-hired non-executive employees under the Employment Inducement Award Plan.

What is the purpose of the Inducement Plan mentioned in the press release by Apollo Medical Holdings, Inc. (AMEH)?

The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of the Company as an inducement material to such individuals' commencement of employment with the Company.

How many shares will vest based on continued employment, and what are the vesting conditions?

Of the restricted stock granted, 22,182 shares will vest over four years in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date. 16,597 shares will vest based on the achievement of applicable performance targets and the same time-based vesting conditions as the other shares of restricted stock granted.

What is the significance of the announcement for Apollo Medical Holdings, Inc. (AMEH) shareholders and employees?

The announcement signifies the company's commitment to attracting and retaining talent by granting equity awards to newly-hired non-executive employees, aligning their interests with the company's long-term success.

Astrana Health, Inc.

NASDAQ:AMEH

AMEH Rankings

AMEH Latest News

AMEH Stock Data

1.83B
34.19M
25.78%
47%
6.06%
Dental Laboratories
Manufacturing
Link
US
Alhambra

About AMEH

apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver quality care to its patients. it offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. the company's physician network consists of primary care physicians, specialist physicians, and hospitalists. it caters to patients, primarily covered by private or public insurance, such as medicare, medicaid, and health maintenance organization plans; and non-insured patients in california. apollo medical holdings, inc. was founded in 1994 and is headquartered in alhambra, california.